Clinical Trial Update: A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics [Phase 2]

View source ↗

Summary

A Phase II clinical trial is evaluating PEG-rhGH injections for improving height in children born small for gestational age, assessing efficacy, safety, and pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Stature in Children Born Small For Gestational Age

Drugs mentioned

• PEG-rhGH Injection (pegylated recombinant human growth hormone)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Short Stature Children Born Small for Gestational Age (SGA) | Phase 2 | Status: RECRUITING